Clinical Trial Update: Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis [Phase 2]

View source ↗

Summary

Phase II study evaluating the effects of rhPDGF-BB injection for lateral epicondylitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lateral Epicondylitis

Drugs mentioned

• rhPDGF-BB (recombinant human platelet-derived growth factor-BB)

Snippet

Sponsor: BioMimetic Therapeutics | Conditions: Lateral Epicondylitis | Phase 2 | Status: COMPLETED | Results posted: 2019-07-02